AstraZeneca
Prescription Drugs · Oncology Therapeutics

AstraZeneca: Ownership & structure

Astrazeneca Intermediate Holdings Limited holds 75–100% of AstraZeneca.

Data updated Nov 21, 2026 · Back to the company report

Owners & entities

Astrazeneca Intermediate Holdings Limited holds 75–100% of AstraZeneca.

Holders
Astrazeneca Intermediate Holdings Limited
ownership of shares 75 to 100 percent; voting rights 75 to 100 percent; right to appoint and remove directors · find-and-update.company-information.service.gov.uk ↗
75–100%
7.69%
Capital Group Companies
owned by · wikidata.org ↗
4.86%
3.93%
Legal entities8 in 6 countries
operator · GB CRN 02723534 · LEI PY6ZZQWO2IZFZC3IOL08
GB
ASTRAZENECA AS
subsidiary
NO
AR
AstraZeneca Oy
subsidiary
FI
4 more records: legal entities with their register numbers and links to each registerProUnlockor this company alone for 30 days · 50 credits
Stakes and purchases
owner of (stated on the holder)
16.29%
owner of (stated on the holder)
10.44%
owner of (stated on the holder)
7.65%
owner of (stated on the holder)
6.66%
subsidiary (stated on the holder)
subsidiary (stated on the holder)
6 more records: acquisitions and stakes, each with its sourceProUnlockor this company alone for 30 days · 50 credits
Large holders (13D / 13G)holders of 5% or more, their newest filing
VANGUARD CAPITAL MANAGEMENT LLC
passive holder · SCHEDULE 13G · Apr 2026
BlackRock, Inc.
passive holder · SCHEDULE 13G/A · Apr 2025
Insider tradesopen-market buys and sales on SEC Form 4, last 12 months

Insiders bought $3.2k (1 people) and sold $2.2M (1 people) in the last 12 months.

Bought · See Remarks
20 shares at $160.57 · Aug 2026
$3.2k
Sold · See Remarks
11,893 shares at $185.78 · May 2026
$2.2M
Holders and shares as each register or filing states them.

Connections

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Same group1
AlexionLikely
alexion.com
Same ATS account
seen Nov 21, 2026 · evidence: 1 Show evidence
Shared investors2
venBio PartnersVia a fund
43 portfolio companies: Sanofi, Insamo, Axent Biosciences and 40 more
222 portfolio companies: Verdiva Bio, PLEASE READ THIS AG, Vivace Therapeutics and 219 more